SARS-CoV-2 variants and genomic surveillance in the low-resource north-west region of Pakistan-Reference-Cited by-同舟云学术

SARS-CoV-2 variants and genomic surveillance in the low-resource north-west region of Pakistan

Published:2024-09-10 Issue:1 Volume:38 Page:
ISSN:1310-2818
Container-title:Biotechnology & Biotechnological Equipment
language:en
Short-container-title:Biotechnology & Biotechnological Equipment

Author:

Shah Muhammad Waseem¹,Qureshi Muhammad Iqbal²,Nasib Khan Ishaq¹³,Zakria Muhammad¹⁴,Ahmad Shahzad¹,Rahim Tariq¹,Ahmad Nasir¹⁴,Muhammad Hafsah¹,Siraj Sami¹⁴,Ali Asif¹⁵,Ahmed Saeed⁶,Harakeh Steve⁷,Yousafzai Yasar Mehmood¹⁵

Affiliation:

1. Public Health Reference Laboratory, Khyber Medical University, Peshawar, Pakistan

2. National Institute of Virology, Dr. Panjwani Center for Molecular Medicine, and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan

3. Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan

4. Institute of Pharmaceutical Sciences, Khyber Medical University, Peshawar, Pakistan

5. Institute of Pathology and Diagnostic Medicine, Khyber Medical University, Peshawar, Pakistan

6. Department of Public Health, TEPHINET, CDC-US, Islamabad, Pakistan

7. King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia

Funder

Health Minister of KP, Pakistan

National Institute of Health, Pakistan

Khyber Medical University Peshawar, Pakistan

Institutional Fund projects

Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13102818.2024.2401163

Reference25 articles.

1. A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. 15 million people have died in the pandemic, WHO says

3. Pathogen Genomics in Public Health

4. Limited resources of genome sequencing in developing countries: Challenges and solutions

5. The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on stability of the RBD–ACE2 complex